Back to Results
First PageMeta Content
Immunosuppressants / Orphan drugs / Amides / Bortezomib / Pyrazines / Dexamethasone / Thalidomide / Multiple myeloma / Lenalidomide / Medicine / Chemistry / Biology


Velcade EPAR summary update II-63 clean
Add to Reading List

Document Date: 2014-02-19 04:10:59


Open Document

File Size: 96,26 KB

Share Result on Facebook

City

London / /

Country

United Kingdom / /

/

Facility

Canary Wharf / /

IndustryTerm

healthcare professionals / /

MedicalCondition

reversible brain disorder / cancer / multiple myeloma / disease / headache / herpes zoster / shingles / neutropenia / nausea / thrombocytopenia / muscle pain / pulmonary hypertension / fever / peripheral neuropathy / tumour lysis syndrome / pericardial disease / acute diffuse infiltrative pulmonary disease / vomiting / fatigue / heart failure / reversible encephalopathy syndrome / infection / high blood pressure / tiredness / constipation / rash / /

MedicalTreatment

catheter / chemotherapy / /

Organization

European Medicines Agency / European Commission / Committee for Medicinal Products for Human Use / European Union / E-mail info@ema.europa.eu Website www.ema.europa.eu An / /

Person

Velcade / /

/

Position

pharmacist / /

Product

Velcade / dexamethasone / cyclophosphamide / prednisone / /

PublishedMedium

the European / /

Technology

chemotherapy / /

URL

www.ema.europa.eu / /

SocialTag